MISSION/HISTORY
  DIRECTOR
  Sylvain Bourgoin     
 
  RESEARCHERS
  Fawzi Aoudjit          
  Pierre Borgeat        
  Maria Fernandes     
  Louis Flamand         
  François Marceau          
  Paul Naccache     
  Patrice Poubelle      
  Marc Pouliot            
  Patrick Provost        
  Raynald Roy            
  Jean Sévigny           
 
  SCIENTIFIC MEETINGS
  PERSONNEL/BUDGET
  VIRTUAL VISIT
  ALUMNI
Any questions?

Webmaster

Pierre BORGEAT, PhD
Professor, Department of Anatomy and Physiology, Faculty of Medicine, Université Laval.


Centre de Recherche en
Rhumatologie et Immunologie
2705, Boulevard Laurier, local T1-49
Quebec, QC
G1V 4G2 Canada
Tel: 418-656-4141 ext. 46166 (office)
Fax: 418-654-2765
E-mail:
Pierre.Borgeat@crchul.ulaval.ca

Research Themes | Research Projects | Selected References | List of Publications | Research Personnel | Additional Information

Research Themes
 

Mechanisms of leukotriene biosynthesis
Regulation of leukotriene biosynthesis by autacoïds
Role of lipid mediators in host defence
Role of lipid mediators in neutrophil migration
Studies on the mechanisms of action of methotrexate

Top of page

 
Research Projects
  >> LEUKOTRIENES, LIPOXINS AND PLATELET-ACTIVATING FACTOR: ASSESSMENT OF BIOLOGICAL SIGNIFICANCE IN NEUTROPHIL TRAFFICKING  

Leukotrienes, lipoxins and platelet-activating factor are lipid mediators of inflammation and potent activators of neutrophil functional responses, including those related to migration/chemotaxis such as adhesion molecule expression, adhesion, enzyme secretion and locomotion. Neutrophil migration from blood towards extravascular space is an essential process of host defense mechanisms. In this project, we investigate the roles of the three classes of lipid mediators in the regulation of neutrophil trafficking. In a first approach, antagonists to the different classes of mediators are used to modulate the trafficking of neutrophils in in vitro and in vivo models. A second approach implicates the use of mice lacking receptors for the lipid mediators (receptor knockout mice). Such studies will define the role of the lipid mediators in the regulation of neutrophil trafficking and might lead to the development of novel anti-inflammatory drugs for the treatment of diseases such as arthritis, psoriasis, asthma, etc.

This project is supported by
the Canadian Institutes of Health Research (CIHR).

Top of page

 
>> MECHANISM OF THE ANTI-INFLAMMATORY ACTIVITY OF METHOTREXATE: INVOLVEMENT OF ADENOSINE AND OF ITS INHIBITORY EFFECTS ON LEUKOTRIENE AND PAF BIOSYNTHESIS  
  Adenosine is a natural substance which possesses potent anti-inflammatory properties; we have already demonstrated that adenosine is a potent inhibitor of the biosynthesis of leukotrienes, a family of mediators of inflammation and allergic reactions. Leukotriene B4, an eicosanoid produced mainly by neutrophils and macrophages, has been shown to be implicated in arthritis (in animal models). In this project, we use a specific animal model involving adenosine A2a receptor-deficient mice to investigate the role of adenosine in the mechanism of action of a drug currently used in the treatment of rheumatoid arthritis, Methotrexate. While the mechanism of action of Methotrexate is still poorly understood, it has been shown that the drug causes the accumulation of adenosine at inflammatory sites, which would be expected to exert an inhibitory effect on leukotriene B4 formation at these sites.

Considering that Methotrexate is one of the most important drugs in the treatment of rheumatoid arthritis patients, it seems very important to better understand its mechanism of action. Such studies could lead to improved therapeutic approaches for the treatment of inflammatory diseases, in particular of rheumatoid arthritis.

This project is supported by
the Canadian Institutes of Health Research (CIHR).

Top of page

 
Selected references  
 

Marleau, S., Fruteau de Laclos, B., Sanchez, A.B., Poubelle, P.E. and Borgeat, P. 1999 Role of 5-lipoxygenase activation and leukotriene B4 LTB4 in the local accumulation of neutrophils in dermal inflammation in the rabbit. J Immunol 163: 3449-3458. PubMed Link

Pouliot, M., Fiset, M.-É., Massé, M., Naccache, P. H. and Borgeat, P. 2002. Adenosine up-regulates cyclooxygenase-2 in human granulocytes: Impact on the balance of eicosanoid generation. J Immunol 169: 5279-5286. PubMed Link

Flamand, N., Surette, M., Picard, S., Bourgoin, S., and Borgeat, P. 2002 Cyclic AMP-mediated Inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils. Mol Pharmacol 62: 250-256. PubMed Link

Flamand, N., Boudreault, S., Picard, S., Austin, M., Surette, M., Plante, H., Krump, E., Vallée, M.-J., Gilbert, C., Naccache, P.H., Laviolette, M., and Borgeat, P. 2000 Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils. Am. J Resp Crit Care Med 161: S88-S94. PubMed Link

Surette, M.E., Krump, E., Picard, S., and Borgeat, P. 1999 Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A2a receptor agonists and crucial role of autocrine activation by leukotriene B4. Mol Pharmacol 56: 1055-1062. PubMed Link

Top of page

 

List of Publications - PubMed Link

Top of page

 
Research Personnel      
  Research Assistant   Graduate Students
  Serge Picard, MSc  

Nicolas Flamand, MSc
Hendrick Plante, MSc
Julie Lefebvre, BSc

Top of page

Additional Information Details